Cargando…
Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease
Intracranial atherosclerotic disease (ICAD) has been characterized by the degree of arterial stenosis and downstream hypoperfusion, yet microscopic derangements of endothelial shear stress at the luminal wall may be key determinants of plaque growth, vascular remodeling and thrombosis that culminate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947292/ https://www.ncbi.nlm.nih.gov/pubmed/33716947 http://dx.doi.org/10.3389/fneur.2021.646309 |
_version_ | 1783663192935759872 |
---|---|
author | Liebeskind, David S. Hinman, Jason D. Kaneko, Naoki Kitajima, Hiroaki Honda, Tristan De Havenon, Adam H. Feldmann, Edward Nogueira, Raul G. Prabhakaran, Shyam Romano, Jose G. Callas, Peter W. Schneider, David J. |
author_facet | Liebeskind, David S. Hinman, Jason D. Kaneko, Naoki Kitajima, Hiroaki Honda, Tristan De Havenon, Adam H. Feldmann, Edward Nogueira, Raul G. Prabhakaran, Shyam Romano, Jose G. Callas, Peter W. Schneider, David J. |
author_sort | Liebeskind, David S. |
collection | PubMed |
description | Intracranial atherosclerotic disease (ICAD) has been characterized by the degree of arterial stenosis and downstream hypoperfusion, yet microscopic derangements of endothelial shear stress at the luminal wall may be key determinants of plaque growth, vascular remodeling and thrombosis that culminate in recurrent stroke. Platelet interactions have similarly been a principal focus of treatment, however, the mechanistic basis of anti-platelet strategies is largely extrapolated rather than directly investigated in ICAD. Platelet FcγRIIa expression has been identified as a potent risk factor in cardiovascular disease, as elevated expression markedly increases the risk of recurrent events. Differential activation of the platelet FcγRIIa receptor may also explain the variable response of individual patients to anti-platelet medications. We review existing data on endothelial shear stress and potential interactions with the platelet FcγRIIa receptor that may alter the evolving impact of ICAD, based on local pathophysiology at the site of arterial stenosis. Current methods for quantification of endothelial shear stress and platelet activation are described, including tools that may be readily adapted to the clinical realm for further understanding of ICAD. |
format | Online Article Text |
id | pubmed-7947292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79472922021-03-12 Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease Liebeskind, David S. Hinman, Jason D. Kaneko, Naoki Kitajima, Hiroaki Honda, Tristan De Havenon, Adam H. Feldmann, Edward Nogueira, Raul G. Prabhakaran, Shyam Romano, Jose G. Callas, Peter W. Schneider, David J. Front Neurol Neurology Intracranial atherosclerotic disease (ICAD) has been characterized by the degree of arterial stenosis and downstream hypoperfusion, yet microscopic derangements of endothelial shear stress at the luminal wall may be key determinants of plaque growth, vascular remodeling and thrombosis that culminate in recurrent stroke. Platelet interactions have similarly been a principal focus of treatment, however, the mechanistic basis of anti-platelet strategies is largely extrapolated rather than directly investigated in ICAD. Platelet FcγRIIa expression has been identified as a potent risk factor in cardiovascular disease, as elevated expression markedly increases the risk of recurrent events. Differential activation of the platelet FcγRIIa receptor may also explain the variable response of individual patients to anti-platelet medications. We review existing data on endothelial shear stress and potential interactions with the platelet FcγRIIa receptor that may alter the evolving impact of ICAD, based on local pathophysiology at the site of arterial stenosis. Current methods for quantification of endothelial shear stress and platelet activation are described, including tools that may be readily adapted to the clinical realm for further understanding of ICAD. Frontiers Media S.A. 2021-02-25 /pmc/articles/PMC7947292/ /pubmed/33716947 http://dx.doi.org/10.3389/fneur.2021.646309 Text en Copyright © 2021 Liebeskind, Hinman, Kaneko, Kitajima, Honda, De Havenon, Feldmann, Nogueira, Prabhakaran, Romano, Callas and Schneider. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Liebeskind, David S. Hinman, Jason D. Kaneko, Naoki Kitajima, Hiroaki Honda, Tristan De Havenon, Adam H. Feldmann, Edward Nogueira, Raul G. Prabhakaran, Shyam Romano, Jose G. Callas, Peter W. Schneider, David J. Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title | Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title_full | Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title_fullStr | Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title_full_unstemmed | Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title_short | Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease |
title_sort | endothelial shear stress and platelet fcγriia expression in intracranial atherosclerotic disease |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947292/ https://www.ncbi.nlm.nih.gov/pubmed/33716947 http://dx.doi.org/10.3389/fneur.2021.646309 |
work_keys_str_mv | AT liebeskinddavids endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT hinmanjasond endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT kanekonaoki endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT kitajimahiroaki endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT hondatristan endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT dehavenonadamh endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT feldmannedward endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT nogueiraraulg endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT prabhakaranshyam endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT romanojoseg endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT callaspeterw endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease AT schneiderdavidj endothelialshearstressandplateletfcgriiaexpressioninintracranialatheroscleroticdisease |